Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline

Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseasesAdvances the Novartis ...

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG

Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA ...

‘The Bermuda Triangle of Talent’: 27-year-old Oxford grad turned down McKinsey and Morgan Stanley to find out why Gen Z’s smartest keep selling out

Simon van Teutem talked to Fortune about “the illusion of infinite choice, and the social status … You’re always looking for ...

How a $130 million donation to US troops raised legal and political questions

The secret benefactor who helped fund troop salaries during the government shutdown is a billionaire with deep ties to ...